»ó´Ü¿©¹é
±â»ç (Àüü 393°Ç)
[Sub Story]
[Çѱ¹ÀÎ ³úÁ¹Áß ¿¹¹æÀ» À§ÇÑ À§ÇèÀÎÀÚ °ü¸®Àü·«]

½ÄÀÌ¡¤º¸Á¶½ÄÇ°º¸´Ù ÁÖ¿ä À§ÇèÀÎÀÚ °ü¸®¿¡ ÃÊÁ¡ ¸ÂÃç¾ß

THE MOST 2020-08-13 10:43
[Conference Report] ¡°¾Æħ°íÇ÷¾Ð Çѱ¹ÀÎ Àý¹ÝÀº Ç÷¾ÐÁ¶Àý ¾ÈµÅ¡± ÀÌ»óµ· ±âÀÚ 2020-08-12 13:04
[Journal Briefing] RAS ¾ïÁ¦Á¦´Â '¾ÈÀü', ½ºÆ®·¹½º´Â '»¡°£ºÒ' ÇãÈñÀ± ±âÀÚ 2020-07-19 18:57
[Sub Story] ¡°¸¸¼º±âħ, ±âÀú¿øÀΰú ±âħ°ú¹ÎÁõ Ä¡·á ÇÔ²² °í·ÁÇؾߡ± ÀÓ¼¼Çü ±âÀÚ 2020-06-03 14:21
[Sub Story] COVID-19 ½Ã´ë ¸¸¼ºÁúȯ °ü¸®Àü·«Àº? ÀÓ¼¼Çü ±âÀÚ 2020-06-03 13:43
¶óÀÎ
[Deep in Guideline] ¾Æ½Ã¾ÆÀÎ ¾ÆħÇ÷¾Ð¡è ¹®Á¦µÉ¼öµµ ÀÌ»óµ· ±âÀÚ 2020-06-03 13:35
[Conference Report] °ü»óµ¿¸ÆÁúȯ¿¡ ´ç´¢º´ µ¿¹Ý, Ä¡·á ¾î¶»°Ô? ÀÓ¼¼Çü ±âÀÚ 2020-06-03 13:32
[Sub Story] ½ºÅ¸Æ¾ + Ç×°íÇ÷¾ÐÁ¦ Áߵ À§Ç豺¿¡¼­´Â? ÀÌ»óµ· ±âÀÚ 2020-05-13 17:30
[Sub Story] ACEI, »ç¸Á·ü±îÁö ³·Ãߴµ¥¡¦ ÀÌ»óµ· ±âÀÚ 2020-05-13 17:16
[Interview] 1Â÷ÀÇ·á °üÁ¡ º¹ÇÕÇü ÀÌ»óÁöÁúÇ÷Áõ °ü¸®

¡°¹«Áõ»ó Ư¼º ÁöÁú ÇÁ·ÎÆÄÀÏ ½Å¼Ó¡¤Àû±Ø °Ë»çÇؾߡ±

ÀÌ»óµ· ±âÀÚ 2020-05-13 16:38
¶óÀÎ
[Drug Review] Ŭ·Î¸£Å»¸®µ· ´õÇØ Ãß°¡Àû Ç÷¾Ð°­ÇÏ È¿°ú ºÎ°¡ ÀÓ¼¼Çü ±âÀÚ 2020-05-12 17:43
[Sub Story] CAD µ¿¹Ý °íÇ÷¾Ð, 130/80mmHg ¹Ì¸¸À¸·Î Á¶Àý ÀÌ»óµ· ±âÀÚ 2020-05-12 17:43
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý SPRINT Ÿ°í Äè¼ÓÁúÁÖ ÀÌ»óµ· ±âÀÚ 2020-05-12 17:42
[Interview] °æÈñÀÇ´ë ±èÁ¾Áø ±³¼ö, ¡°±¹³» °íÇ÷¾Ð ȯÀÚ Ä¡·áÀÇ ÀÌÁ¤Ç¥ µÉ °Í¡± ÀÌ»óµ· ±âÀÚ 2020-05-12 17:40
[Sub Story] µ¿¹ÝÀÌȯÀ² 50% ¿ôµµ´Âµ¥ µ¿¹ÝÄ¡·áÀ²Àº ÇÑÂü ¹Øµ¹¾Æ ÀÌ»óµ· ±âÀÚ 2020-05-12 17:21
¶óÀÎ
[Sub Story] ¾ÆÁú»ç¸£Åº ¸Þµ¶¼Ò¹Ð °­·Â¡¤¾ÈÀü Ç÷¾Ð°­ÇÏ Çѱ¹Àο¡¼­ ÀçÇö ÀÌ»óµ· ±âÀÚ 2020-05-12 17:12
[Sub Story] ±¹»ê ARB, Çѱ¹ÀÎ ´ë»ó 1 ´ë 1 ºñ±³ÀÓ»ó ÁÖ¸ñ ÀÌ»óµ· ±âÀÚ 2020-05-12 17:08
[Sub Story] Çѱ¹Àο¡¼­ ÇǸ¶»ç¸£ÅºÀÇ 3¹ÚÀÚ ½Å¼Ó¡¤°­·Â¡¤Áö¼Ó Ç÷¾Ð°­ÇÏ ÀÌ»óµ· ±âÀÚ 2020-05-12 17:05
[Sub Story] ¾Ï·ÎµðÇÉ/·Î»ç¸£Åº Áß½ÉÇ÷¾Ð 24½Ã°£ ¾ÈÁ¤Àû °­ÇÏ ÀÌ»óµ· ±âÀÚ 2020-05-12 16:31
[Sub Story] ´Ù¾çÇÑ Ç÷¾ÐÃøÁ¤ ¹Ýº¹À¸·Î º¯µ¿¼º °É·¯³»¾ß ÀÌ»óµ· ±âÀÚ 2020-05-12 15:58
Back to Top